JAZZ insider buying – Jazz Pharmaceuticals plc
8 insider purchases since 2016 worth $24.7M by 4 different insiders. Last 12 months: 0 purchases, $0. Most recent filing: 2025-05-13.
Large company Public float $6.3B (latest 10-K, SEC).
Same time range as the chart above - each mark sits under the week of the trade. Circles = purchases (height = price paid, size = amount), red triangles = open-market sales of $50k+. Prices as reported, not adjusted for later stock splits. 6 older purchases (before the 5-year window) are listed in the table below.
Purchases are open-market buys (SEC Form 4, code "P") - insiders paying with their own money. Sales are open-market sales (code "S") of $50,000 or more; many sales are pre-planned (Rule 10b5-1) or made for taxes and diversification. Each row links to the original filing.
Bought, sold, still holding?
| Insider | Bought | First / last buy | Sold since 2016 | Holds now* | Status |
|---|---|---|---|---|---|
| Mulligan Seamus Director | $22.8M 3× · 201,621 sh | 2018-11-15 2025-05-09 | 3× · $11.2M last 2016-08-25 | 1,286,254 shares as of 2026-08-07 | Holds (sold earlier) |
| Johnson Philip L CFO | $1.4M 1× · 12,000 sh | 2024-03-01 2024-03-01 | – | 56,431 shares as of 2026-07-02 | Holds - never sold |
| Smith Karen L. Officer | $249,995 3× · 1,745 sh | 2016-06-13 2016-08-12 | – | 28,474 shares as of 2018-03-07 | Holds - never sold |
| O'Keefe Kenneth W Director | $227,684 1× · 2,000 sh | 2016-11-11 2016-11-11 | 5× · $3.4M last 2023-03-07 | 30,256 shares as of 2025-12-04 | Sold part |
* Shares held after the insider's most recent SEC filing for this company (all share classes, direct and indirect). If an insider stops filing, later changes are not known.
Insider buying and selling by year
| Year | Purchases | Bought | Buyers | Sales | Sold |
|---|---|---|---|---|---|
| 2026 | 0 | – | – | 22 | $62.2M |
| 2025 | 1 | $10.0M | 1 | 23 | $28.3M |
| 2024 | 1 | $1.4M | 1 | 6 | $1.9M |
| 2023 | 0 | – | – | 15 | $4.1M |
| 2022 | 0 | – | – | 37 | $29.8M |
| 2021 | 0 | – | – | 20 | $10.8M |
| 2020 | 1 | $5.6M | 1 | 20 | $9.1M |
| 2019 | 0 | – | – | 15 | $5.7M |
| 2018 | 1 | $7.2M | 1 | 38 | $14.9M |
| 2017 | 0 | – | – | 23 | $13.2M |
| 2016 | 4 | $477,679 | 2 | 20 | $17.8M |
Insider purchases
| Filed | Insider | Role | Shares | Avg price | Value | Holdings | Filing |
|---|---|---|---|---|---|---|---|
| 2025-05-13 | Mulligan Seamus | Director | 101,621 | $98.33 | $10.0M | SEC | |
| 2024-03-05 | Johnson Philip L | CFO | 12,000 | $119.65 | $1.4M | +75.3% | SEC |
| 2020-05-27 | Mulligan Seamus | Director | 50,000 | $111.08 | $5.6M | +4.5% | SEC |
| 2018-11-19 | Mulligan Seamus | Director | 50,000 | $144.56 | $7.2M | +4.8% | SEC |
| 2016-11-15 | O'Keefe Kenneth W | Director | 2,000 | $113.84 | $227,684 | SEC | |
| 2016-08-12 | Smith Karen L. | Officer | 608 | $137.10 | $83,357 | +4.5% | SEC |
| 2016-07-13 | Smith Karen L. | Officer | 580 | $143.63 | $83,305 | +4.5% | SEC |
| 2016-06-15 | Smith Karen L. | Officer | 557 | $149.61 | $83,333 | +4.5% | SEC |
Insider sales
| Filed | Insider | Role | Shares | Avg price | Value | Type | Filing |
|---|---|---|---|---|---|---|---|
| 2026-11-10 | COZADD BRUCE C | Director | -68,808 | $235.95 | $16.2M | Sale | SEC |
| 2026-09-14 | Patil Neena M | Officer | 1,200 | $240.94 | $289,128 | Pre-planned (10b5-1) | SEC |
| 2026-09-10 | GALA RENEE D | CEO | 2,000 | $243.03 | $486,060 | Pre-planned (10b5-1) | SEC |
| 2026-09-02 | COZADD BRUCE C | Director | 6,000 | $250.13 | $1.5M | Pre-planned (10b5-1) | SEC |
| 2026-08-31 | Iannone Robert | Officer | 76,921 | $249.70 | $19.2M | Pre-planned (10b5-1) | SEC |
| 2026-08-05 | COZADD BRUCE C | Director | 6,000 | $252.98 | $1.5M | Pre-planned (10b5-1) | SEC |
| 2026-07-06 | COZADD BRUCE C | Director | 6,000 | $240.47 | $1.4M | Pre-planned (10b5-1) | SEC |
| 2026-06-17 | Smith Mark Douglas | Director | 1,157 | $230.55 | $266,746 | Pre-planned (10b5-1) | SEC |
| 2026-06-12 | Patil Neena M | Officer | 1,200 | $231.83 | $278,196 | Pre-planned (10b5-1) | SEC |
| 2026-06-03 | COZADD BRUCE C | Director | 6,000 | $235.12 | $1.4M | Pre-planned (10b5-1) | SEC |
| 2026-06-01 | Pearce Samantha | Officer | 6,907 | $235.41 | $1.6M | Sale | SEC |
| 2026-06-01 | Patil Neena M | Officer | 1,192 | $236.97 | $282,468 | Pre-planned (10b5-1) | SEC |
| 2026-05-27 | Winningham Rick E | Director | 2,741 | $241.57 | $662,143 | Sale | SEC |
| 2026-05-27 | McSharry Heather Ann | Director | 2,000 | $241.00 | $482,000 | Sale | SEC |
| 2026-05-05 | COZADD BRUCE C | Director | 6,000 | $203.33 | $1.2M | Pre-planned (10b5-1) | SEC |
Showing the latest 15 of 239 sales of $50,000+ since 2016.
Compiled automatically from public SEC filings. Not investment advice. Get every new insider purchase in the daily report.
Get every new insider purchase the day it's filed
Daily report with all SEC insider buys, cluster buys, company events and the crypto money-flow radar.
Get started free